Advanced Investment Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Advanced Investment Partners’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$74K	Buy	+8,982	New	+$70K	0.13%	149

Other funds holding PDLI

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Advanced Investment Partners's PDLI Position: Q2 2013 in Review

Advanced Investment Partners opened a new position in PDL BioPharma, Inc. (PDLI) in Q2 2013: 8,982 shares worth $74K. The stake represents 0.13% of the portfolio and ranks #149 among its holdings.

202 funds tracked by Wall St. Rank hold PDLI as of Q2 2013.

Advanced Investment Partners held 8,982 shares of PDL BioPharma, Inc. worth $74K as of Q2 2013.
PDL BioPharma, Inc. was a new Advanced Investment Partners position in Q2 2013.
PDL BioPharma, Inc. made up 0.13% of Advanced Investment Partners's portfolio in Q2 2013, its #149 holding.
202 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2013.

Based on Advanced Investment Partners's 13F filing for Q2 2013, filed 16 Aug 2013.